SUBSCRIBE
SUBSCRIBE
News   Policy

Ranbaxy Laboratories Gains in Mumbai After U.S. Withdraws Motion

October 9, 2008 | 
1 min read
Oct. 8 (Bloomberg) -- Ranbaxy Laboratories Ltd., the Indian drugmaker being purchased by Japan's Daiichi Sankyo Co., rose the most in almost three months after the U.S. withdrew a motion seeking to force the company to turn over audit reports.
Legal Regulatory Asia
MORE ON THIS TOPIC
Composite contemporary collage statue of justice themis femida on the background of the target as the concept and idea of justice and law. High quality photo
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
January 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of woman checking progress on project
Opinion
FDA Inspections Should Not Be Source of Stress
January 27, 2026
 · 
5 min read
 · 
Greg Walker
Capitol in Washington
Government
Spending Bill Clears House, Keeping Priority Review Voucher Hopes Alive
January 23, 2026
 · 
3 min read
 · 
Tristan Manalac
Government red tape concept and American bureaucracy symbol as an icon of the flag of the United States with the red stripes getting tangled in confusion as a metaphor for political and administration inefficiency.
Rare diseases
Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way
January 23, 2026
 · 
3 min read
 · 
Heather McKenzie